Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration
Go back to Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 1.11 +0.08 (7.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $0.00 | |||
| Open | $1.19 | 52 Week Low | $0.00 | |||
| Day High | $1.36 | P/E | N/A | |||
| Day Low | $1.05 | EPS | $0.00 | |||
| Volume | 22,537,647 | |||||
| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 1.11 +0.08 (7.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $0.00 | |||
| Open | $1.19 | 52 Week Low | $0.00 | |||
| Day High | $1.36 | P/E | N/A | |||
| Day Low | $1.05 | EPS | $0.00 | |||
| Volume | 22,537,647 | |||||
